Is PRXL a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

343 people get PRXL articles and Market Currents by email alert.

Get email alerts on PRXL »

HEADLINES:

PAREXEL International Management Discusses Q3 2013 Results - Earnings Call Transcript
Wed, May 1
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results

PR Newswire (Apr 30, 2013)
PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy

PR Newswire (Apr 30, 2013)
PAREXEL Honored with 2013 "Partnership Pioneers of the Year" Award

PR Newswire (Apr 24, 2013)
New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry

PR Newswire (Apr 22, 2013)
PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call

PR Newswire (Apr 2, 2013)
PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan

PR Newswire (Mar 14, 2013)
PAREXEL International's Management Presents at Barclays Global Healthcare Conference (Transcript)
Tue, Mar 12
PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference

PR Newswire (Feb 28, 2013)
PAREXEL International's Management Presents at Citi 2013 Global Healthcare Conference (Transcript)
Wed, Feb 27
PAREXEL International To Present At Citi Global Healthcare Conference

PR Newswire (Feb 20, 2013)
PAREXEL International Management Discusses Q2 2013 Results - Earnings Call Transcript
Wed, Jan 30
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results

PR Newswire (Jan 29, 2013)
PAREXEL Announces Xavier Flinois as Incoming President of Perceptive Informatics

PR Newswire (Jan 22, 2013)
PAREXEL Chairman and CEO Josef von Rickenbach Elected 2013 ACRO Chairman

PR Newswire (Jan 10, 2013)
PAREXEL International To Present At J.P. Morgan Healthcare Conference

PR Newswire (Jan 4, 2013)
These 3 Stocks Have A History Of Q1 Gains
Todd Campbell • Thu, Jan 3 • 9 Comments
PAREXEL Announces Date Of Second Quarter Fiscal Year 2013 Earnings Release And Conference Call

PR Newswire (Jan 3, 2013)
Strengthening Moats Mean Improving Returns For CRO Investors
Morningstar • Mon, Dec 31, 2012
PAREXEL International Announces Acquisition of Liquent, Inc., and Updates Financial Guidance

PR Newswire (Dec 27, 2012)

To learn more about Seeking Alpha Pro, click here.

Keeping an Eye on Parexel International
TraderMark • Tue, Apr 15, 2008
Parexel: Put on the Radar
Tate Dwinnell • Thu, Jan 10, 2008
Parexel Posts Impressive Quarter; Estimates Should Continue to Climb
Notable Calls • Tue, Aug 7, 2007

These 3 Stocks Have A History Of Q1 Gains
Todd Campbell • Thu, Jan 3 • 9 Comments
Strengthening Moats Mean Improving Returns For CRO Investors
Morningstar • Mon, Dec 31, 2012
6 Growth Stocks With Positive Momentum And Low Debt
Arie Goren • Thu, Nov 15, 2012 • 1 Comment
Active Bear Fund Exits Zynga, Currently Short Groupon And OpenTable
Richard Bloch • Tue, Jul 31, 2012 • 14 Comments
Update: 8 High-Growth Healthcare Stocks With Strong Sources Of Profitability
Kapitall • Tue, Jul 17, 2012
8 Undervalued Healthcare Stocks With Strong Receivable Trends
Kapitall • Thu, Jun 21, 2012
8 High-Growth Healthcare Stocks With Strong Sources Of Profitability
Kapitall • Tue, Jun 12, 2012
Sector Detector: Strong Earnings Balance Global Worries
Scott Martindale • Thu, May 3, 2012
Merck's Transition Will Make It A More Profitable Company
Jacob Steinberg • Tue, Mar 13, 2012 • 4 Comments
16 Rallying Healthcare Stocks Being Sold By Hedge Funds
Kapitall • Tue, Feb 21, 2012
Contract Research Organizations Still On Sale As Industry Rebounds
Morningstar • Thu, Jan 12, 2012
Leading CROs Will Gain From Drug Research Rebound
Morningstar • Mon, Oct 3, 2011
Platform and Specialty Pharmaceutical Companies Could Strengthen in Face of Big Pharma's Patent Cliff
Tro Kalayjian • Fri, May 27, 2011 • 19 Comments
Wall Street Breakfast: Must-Know News
SA Editor Yigal Grayeff • Tue, May 3, 2011 • 19 Comments
Tocqueville Asset Management Top 15 Buys
The Analyst Hub • Tue, May 3, 2011 • 4 Comments
Contract Research (CROs): On the Brink of Recovery
Morningstar • Fri, Apr 15, 2011 • 1 Comment
Short Ideas: 4 Companies Cutting Guidance With Rising Receivables
Kapitall • Tue, Mar 1, 2011 • 3 Comments
The Emerging Market Healthcare Trend That Nobody Is Talking About
Marc Lichtenfeld • Thu, Jan 27, 2011 • 3 Comments
Merck Enlists Parexel to Support Development of Promising Biosimilars
The Burrill Report • Sun, Jan 16, 2011
CRO Investment Opportunities Remain Compelling
Morningstar • Thu, Nov 11, 2010

PAREXEL International Management Discusses Q3 2013 Results - Earnings Call Transcript
Wed, May 1
PAREXEL International's Management Presents at Barclays Global Healthcare Conference (Transcript)
Tue, Mar 12
PAREXEL International's Management Presents at Citi 2013 Global Healthcare Conference (Transcript)
Wed, Feb 27
PAREXEL International Management Discusses Q2 2013 Results - Earnings Call Transcript
Wed, Jan 30
PAREXEL International Corporation F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
Tue, Jan 26, 2010
PAREXEL International Corp. F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
Tue, Aug 11, 2009
PAREXEL International Corp, F3Q09 (Qtr End 03/31/2009) Earnings Call Transcript
Tue, Apr 28, 2009
PAREXEL International Corporation F2Q09 (Qtr End 12/31/08) Earnings Call Transcript
Tue, Jan 27, 2009
PAREXEL International Corp. F1Q09 (Qtr End 9/30/08) Earnings Call Transcript
Tue, Oct 28, 2008
PAREXEL International Corp. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
Mon, Aug 18, 2008
Parexel International Corp. F3Q08 (Qtr End 03/31/08) Earnings Call Transcript
Tue, Apr 29, 2008 • 1 Comment
PAREXEL International Corporation F2Q08 (Qtr End 12/31/07) Earnings Call Transcript
Mon, Feb 18, 2008

Cramer: This Fresh-Faced IPO Still a Buy

at CNBC.com (May 13, 2013)
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results

PR Newswire (Apr 30, 2013)
PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy

PR Newswire (Apr 30, 2013)
PAREXEL Honored with 2013 "Partnership Pioneers of the Year" Award

PR Newswire (Apr 24, 2013)
New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry

PR Newswire (Apr 22, 2013)
PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call

PR Newswire (Apr 2, 2013)
PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan

PR Newswire (Mar 14, 2013)
PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference

PR Newswire (Feb 28, 2013)
PAREXEL International To Present At Citi Global Healthcare Conference

PR Newswire (Feb 20, 2013)
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results

PR Newswire (Jan 29, 2013)
PAREXEL Announces Xavier Flinois as Incoming President of Perceptive Informatics

PR Newswire (Jan 22, 2013)
PAREXEL Chairman and CEO Josef von Rickenbach Elected 2013 ACRO Chairman

PR Newswire (Jan 10, 2013)
PAREXEL International To Present At J.P. Morgan Healthcare Conference

PR Newswire (Jan 4, 2013)
PAREXEL Announces Date Of Second Quarter Fiscal Year 2013 Earnings Release And Conference Call

PR Newswire (Jan 3, 2013)
PAREXEL International Announces Acquisition of Liquent, Inc., and Updates Financial Guidance

PR Newswire (Dec 27, 2012)
Perceptive Informatics Opens First Customer Care Office in China

PR Newswire (Dec 10, 2012)
PAREXEL International To Present At Oppenheimer Healthcare Conference

PR Newswire (Dec 5, 2012)
Perceptive Informatics' Randomization Technologies Used in More Than 3,000 Clinical Trials for Improved Data Access and Faster Decision Making

PR Newswire (Dec 4, 2012)
PAREXEL and National Taiwan University Hospital Enter Partnership to Support Clinical Research in Taiwan

PR Newswire (Nov 27, 2012)
PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference

PR Newswire (Nov 7, 2012)

PRXL vs. ETF Alternatives

Company Description

Currently, there's no company description for PRXL.

Sector: Healthcare

Industry: Medical Laboratories & Research

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, April 30, 5:13 PM PAREXEL (PRXL): Q1 EPS of $0.50 beats by $0.10. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, March 14, 4:15 PM Parexel (PRXL) accelerates its buyback program by adding an additional $50M in a new ASR agreement, bringing both programs to a total of $100M. Both plans are with JP Morgan Securities. Comment! [Healthcare]
Tuesday, January 29, 5:55 PM More on Parexel (PRXL): FQ2 beats across the board on a 26% jump in total revenue. Net earnings climbed 65% on higher demand for its clinical R&D services and data analysis. Service revenue rose 27% to $422.1M, with newly-acquired Liquent contributing $400K in the quarter. Backlog at the end of December was approximately $4.54B, up 21.4% Y/Y. It also raises FY guidance, now expecting to earn $1.48 to $1.56 per share, with consolidated service revenue between $1.695B and $1.710B. Shares +3.4% AH. Comment! [Healthcare, Earnings]
Tuesday, January 29, 4:06 PM PAREXEL (PRXL): FQ2 EPS of $0.41 beats by $0.08. Revenue of $422.1M (+26.7% Y/Y) beats by $2.32M. Shares -0.5% AH. (PR) Comment! [Earnings, Breaking News]
Thursday, December 27, 2012, 2:09 PM Synergy Pharmaceuticals (SGYP +5.3%) moves up after saying its commenced Phase IIb clinical trials of plecanatide, a treatment for patients with constipation-predominant irritable bowel syndrome. The trial is being conducted at 70 sites in the U.S. and includes 350 patients. Parexel International (PRXL -2%) is the contract research organization for the trial. Comment! [Healthcare, On the Move]
Thursday, December 27, 2012, 9:17 AM Parexel (PRXL +2.1%) acquires Liquent for $72M. The shares rose after the firm raised 2Q13 revenue guidance to $415M-$420M, GAAP EPS to be in range of $0.31-$0.34 and FY13 revenue of $1.67B-$1.69B and adj. EPS to be in range of $1.36-$1.43. The acquisition is expected to have dilutive impact of $0.02-$0.04 for FY13. (PR) Comment! [On the Move, Healthcare]
Tuesday, October 30, 2012, 6:08 PM More on Parexel (PRXL) FQ1 EPS comes in-line but its top-line beats on a 25% jump in Y/Y revenue. For the current quarter, the company expects to report service revenue in the range of $400M to $410M and an EPS in the range of $0.31 to $0.33. For FY13, service revenue is expected to be in the range of $1.63B to $1.66B on earnings between $1.34 to $1.44. Comment! [Earnings]
Tuesday, October 30, 2012, 5:56 PM Parexel International (PRXL): FQ1 EPS of $0.29 in-line. Revenue of $462.5M (+25.5% Y/Y) beats by $66M. (PR) Comment! [Earnings, Healthcare]
Monday, September 17, 2012, 5:30 PM Parexel (PRXL) announces an Accelerated Share Repurchase agreement with JPMorgan to repurchase an aggregate of $50M of the company's common stock. The purchase is part of its existing $200M share repurchase program announced in August, and will conducted as part of a 10b5-1 trading plan that allows JPMorgan to make purchases on the company's behalf. Comment! [Healthcare]
Wednesday, August 8, 2012, 6:58 PM PAREXEL International (PRXL): FQ4 EPS of $0.34 beats by $0.05. Revenue of $457.7M (+25.9% Y/Y) beats by $80M. (PR) Comment! [Earnings, Healthcare]
Monday, April 30, 2012, 5:20 PM PAREXEL International (PRXL): FQ3 EPS of $0.33 beats by $0.02. Revenue of $356M (+18.1% Y/Y) beats by $6M. Shares -7% AH. (PR) Comment! [Earnings, Healthcare, On the Move]
Monday, January 30, 2012, 5:45 PM More on Parexel's FQ2: Though results were only in-line, the company is guiding for FQ3 revenue of $350M-$358M ($334.2M consensus) and EPS of $0.30-$0.32 ($0.23 consensus). In addition, it's guiding for FY12 (ends in June) revenue of $1.36B-$1.375B ($1.36B consensus) and EPS of $1.09-$1.17 ($1.11 consensus). PRXL now +10% AH. (PR) Comment! [Healthcare, Earnings, On the Move]
Monday, January 30, 2012, 4:26 PM Parexel International (PRXL): FQ2 EPS of $0.23 in-line. Revenue of $333.2M (+9.5% Y/Y) in-line. Shares +0.7% AH. (PR) Comment! [Earnings, Healthcare]
Wednesday, August 10, 2011, 3:56 PM Shares of Parexel (PRXL +9.3%) jump after the firm raised its FY12 outlook on revenue to $1.36B-$1.4B, from $1.34-$1.38B, and received an upgrade from Jefferies to Hold. Revenue only jumped 5% Y/Y for the firm, but backlogs increased 29% on new business wins. Comment! [On the Move, Tech]
Monday, May 23, 2011, 12:49 PM Parexel (PRXL) has been hard hit today, -5.7% after Goldman Sachs downgrades the stock to Sell from Neutral, citing a lack of visibility, margin pressures, and overly aggressive second-half earnings growth projections. Comment! [Healthcare, On the Move, Quick Ideas]
Tuesday, May 3, 2011, 9:00 AM Premarket gainers: KLIC +15%. BPI +10%. PCS +6%. FE +5%. AVP +5%. REE +4%. AVL +4%. LVLT +3%. FCEL +3%. VVUS +3%. CTIC +3%.
Losers: PRXL -18%. ANAD -15%. COOL -10%. LPSN -5%. TAP -5%. CTSH -4%. PRGO -4%. KEG -3%. CHK -3%. TTM -3%. AG -3%. OC -3%. 1 Comment [On the Move]

Michael Bryant
Big 5 Sporting ($BGFV), Spirit Airlines ($SAVE), PAREXEL ($PRXL), Overstock.com ($OSTK), & Dorman Products ($DORM) rose Wed on unusual vol.
May 1, 11:24 PM
Reply (2)

• !Report Abuse
View all 2 replies
Michael Bryant: $DORM is the only one here that consistently goes up. http://yhoo.it/ZSXmy4;c=
May 1, 11:30 PM
• !Report Abuse
Michael Bryant: But I think $OSTK is the next $AMZN.
May 1, 11:31 PM
• !Report Abuse
Add a reply...

140 characters

Jim Van Meerten
$PRXL - 100% Barchart technical buy signals - 5 new highs and up 8.71% in hte last month - Relative strength Index 68.34%
May 1, 11:07 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Returning Upgrades (4/11/13): $MGA, $MIC, $MMC, $NEOG, $NUVA, $PAYX, $PBJ, $PCL, $PCRX, $PFF, $PM, $POWR, $PRGO, $PRXL, $QGEN, $RDEN
Apr 12, 10:33 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
DaVita HealthCare Partners ($DVA), Hertz Global ($HTZ), PAREXEL ($PRXL), Biogen Idec ($BIIB), & Conn's ($CONN) rose Tuesday on unusual vol.
Apr 3, 2:51 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: Only $DVA and $BIIB look good longterm buys.
Apr 3, 2:57 AM
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Stepan Company ($SCL), Meritage Homes ($MTH), Tredegar ($TG), PAREXEL International ($PRXL), & Lindsay ($LNN) rose Friday on unusual volume.
Mar 18, 12:04 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: I like $MTH and $LNN.
Mar 18, 12:08 AM
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
PAREXEL ($PRXL), Kroger ($KR), Regeneron Pharmaceuticals ($REGN), HDFC Bank ($HDB), & SouFun ($SFUN) rose Thursday on unusual volume.
11/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Middleby Corporation (MIDD), PetSmart (PETM), Portfolio Recovery (PRAA), PAREXEL (PRXL), & Akamai (AKAM) rose Thursday on unusual volume.
11/16/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dividend Sheet
Biggest Players Within Medical Laboratories And Research Industry ++ http://t.co/qNeUzk4 ++ $LH $DGX $CVD $ALR $PPDI $ICLR $IRWD $PRXL
5/29/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Justin M. Hall
ZIOP, NBY, EBS, ABT, PRXL, CERN, ACT, CBRX => Notable Developments and Results 12/6/10 => Rx Investors.com => http://bit.ly/c9Kc5C
12/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Alex B. Gray
Parexel $PRXL reported FY2011 Q1 revenue increased 13.9% to $295.8M and diluted earnings per share increased 42.9% to $0.30.
11/2/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Michael Bryant
Big 5 Sporting ($BGFV), Spirit Airlines ($SAVE), PAREXEL ($PRXL), Overstock.com ($OSTK), & Dorman Products ($DORM) rose Wed on unusual vol.
May 1, 11:24 PM
Reply (2)

• !Report Abuse
View all 2 replies
Michael Bryant: $DORM is the only one here that consistently goes up. http://yhoo.it/ZSXmy4;c=
May 1, 11:30 PM
• !Report Abuse
Michael Bryant: But I think $OSTK is the next $AMZN.
May 1, 11:31 PM
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
DaVita HealthCare Partners ($DVA), Hertz Global ($HTZ), PAREXEL ($PRXL), Biogen Idec ($BIIB), & Conn's ($CONN) rose Tuesday on unusual vol.
Apr 3, 2:51 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: Only $DVA and $BIIB look good longterm buys.
Apr 3, 2:57 AM
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Stepan Company ($SCL), Meritage Homes ($MTH), Tredegar ($TG), PAREXEL International ($PRXL), & Lindsay ($LNN) rose Friday on unusual volume.
Mar 18, 12:04 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: I like $MTH and $LNN.
Mar 18, 12:08 AM
• !Report Abuse
Add a reply...

140 characters

PRXL PAREXEL International Corporation

PRXL

PAREXEL International Corporation